Skip to main content
An official website of the United States government
Email

Advancing Cancer Health Disparities Research Globally at the AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved 2021

October 6, 2021 | 3:45 PM – 5:15 PM

Add to Outlook Calendar

View Program

Advancing Cancer Health Disparities Research Globally 

Advances in cancer research have resulted in a decline in overall cancer incidence and deaths, and an increase in the number of cancer survivors globally. However, this progress has not benefitted everyone equally with certain populations experiencing significant disparities in cancer risk and outcomes. Cancer health disparities are a global problem that remain incompletely understood at the global level. While there are diverse definitions of health disparities, there remains a need to better define global cancer health disparities, considering the complex and multifaceted determinants across low- and middle-income countries. A global approach to studying cancer health disparities offers opportunities to understand and develop adaptable interventions and solutions that cut across multiple settings.  This session aims to develop a consensus understanding among the scientific community on definitions, priorities, and opportunities to systematically study and address cancer health disparities globally.

Part 1: Presentations

Session Chair- James Alaro, Ph.D.

  • Global Cancer Health Disparities: a Definition Proposed by NCI; James Alaro, Ph.D. 
  • Why Study Cancer Health Disparities Globally; US and Global Perspectives; Camille Ragin, Ph.D., Fox Chase Cancer Center 
  • Understanding Global Cancer Health Disparities; a Systems Thinking Approach; Peter Hovmand, Ph.D., Case Western Reserve University 

Part 2: Panel Discussion

Facilitator: Satish Gopal, M.D., MPH

  • Definition, Cross-Cutting Themes, Research Priorities, Opportunities
  • Barriers and Facilitators to Advancing Cancer Health Disparities Research Globally 

Panelists: Camille Ragin, Ph.D., Fox Chase Cancer Center; Peter Hovmand, Ph.D., Case Western Reserve University; CS Pramesh, M.D., Tata Memorial Hospital; Martin Lajous, M.D., Instituto Nacional de Salud Pública

Email